Brain-Injected gene therapy tested for genetic form of Parkinson's
NCT ID NCT07414290
Summary
This early-stage study is testing a new gene therapy called VGN-R08b for Parkinson's disease in people who have a specific genetic change (GBA1 mutation). The therapy is injected directly into the fluid around the brain. The main goals are to first check if it's safe and tolerable, and then to see if it can improve Parkinson's symptoms and related biological markers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xiangya Hospital, Central South University
Changsha, Hunan, 410008, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.